Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin

Geranylgeranylacetone, a Gastromucoprotective Drug, Protects Against NSAID-induced Esophageal, Gastroduodenal and Small Intestinal Mucosal Injury in Healthy Subjects: A Prospective Randomized Study Involving a Comparison with Famotidine

(2014) Eiji Umegaki et al.   INTERNAL MEDICINE

Impact of CYP2C19 Polymorphism and Proton Pump Inhibitors on Platelet Reactivity to Clopidogrel and Clinical Outcomes Following Stent Implantation

(2014) Seiji Hokimoto et al.   THROMBOSIS RESEARCH

Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers

(2013) Christian Funck-Brentano et al.   Archives of Cardiovascular Diseases

Effects of Helicobacter pylori Infection on Long-term Risk of Peptic Ulcer Bleeding in Low-Dose Aspirin Users

(2013) Francis K.L. Chan et al.   GASTROENTEROLOGY

Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study

(2013) Kentaro Sugano et al.   GUT

Efficacy of Twice-Daily Rabeprazole for Reflux Esophagitis Patients Refractory to Standard Once-Daily Administration of PPI: The Japan-Based TWICE Study

(2012) Yoshikazu Kinoshita et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Management of Patients With Ulcer Bleeding

(2012) Loren Laine et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ability of Rabeprazole to Prevent Gastric Mucosal Damage From Clopidogrel and Low Doses of Aspirin Depends on CYP2C19 Genotype

(2012) Takahiro Uotani et al.   Clinical Gastroenterology and Hepatology

Effects of PPIs and an H2 blocker on the Antiplatelet Function of Clopidogrel in Japanese Patients under Dual Antiplatelet Therapy

(2012) Keiichiro Yamane et al.   Journal of Atherosclerosis and Thrombosis

Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial

(2012) Tsuyoshi Sanuki et al.   JOURNAL OF GASTROENTEROLOGY

Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4

(2012) Masato Ohbuchi et al.   XENOBIOTICA

Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer

(2011) J.-C. Luo et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention

(2011) S. D. Saini et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

(2011) Sidney C. Smith et al.   CIRCULATION

Dose–response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes

(2011) Seiichi Hayato et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)

(2011) J. M. Scheiman et al.   HEART

Influence of Different Proton Pump Inhibitors on Activity of Cytochrome P450 Assessed by [13C]-Aminopyrine Breath Test

(2011) Chise Kodaira et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial

(2011) Kentaro Sugano et al.   JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

(2010) Y. Kinoshita et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

(2010) Neena S Abraham et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers

(2009) Masafumi Nishino et al.   DIGESTIVE DISEASES AND SCIENCES

Absence of Influence of Concomitant Administration of Rabeprazole on the Pharmacokinetics of Tacrolimus in Adult Living-donor Liver Transplant Patients: A Case–control Study

(2009) Keiko Hosohata et al.   Drug Metabolism and Pharmacokinetics

A Role for HSP70 in Protecting against Indomethacin-induced Gastric Lesions

(2009) Shintaro Suemasu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Esophageal Mucosal Injury With Low-Dose Aspirin and Its Prevention by Rabeprazole

(2009) Mitsushige Sugimoto et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy

(2009) Masayuki Nakayama et al.   JOURNAL OF GASTROENTEROLOGY

Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin

(2008) Neville Yeomans et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease

(2008) Hiroaki Nema et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Proton Pump Inhibitors May Increase the Risk of Delayed Bleeding Complications after Open Heart Surgery if Used Concomitantly with Warfarin

(2008) M. Hata et al.   THORACIC AND CARDIOVASCULAR SURGEON